{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:33:54Z","timestamp":1792247634735,"version":"4.4.0"},"reference-count":56,"publisher":"National Academy of Sciences","issue":"15","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.pnas.org\/site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM088558"],"award-info":[{"award-number":["U54GM088558"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007535-16A1"],"award-info":[{"award-number":["T32AI007535-16A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["K08-AI104767"],"award-info":[{"award-number":["K08-AI104767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2017,4,11]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Quarantine and symptom monitoring of contacts with suspected exposure to an infectious disease are key interventions for the control of emerging epidemics; however, there does not yet exist a quantitative framework for comparing the control performance of each intervention. Here, we use a mathematical model of seven case-study diseases to show how the choice of intervention is influenced by the natural history of the infectious disease, its inherent transmissibility, and the intervention feasibility in the particular healthcare setting. We use this information to identify the most important characteristics of the disease and setting that need to be considered for an emerging pathogen to make an informed decision between quarantine and symptom monitoring.<\/jats:p>","DOI":"10.1073\/pnas.1616438114","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T20:20:17Z","timestamp":1490732417000},"page":"4023-4028","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":244,"title":["Comparing nonpharmaceutical interventions for containing emerging epidemics"],"prefix":"10.1073","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-5318","authenticated-orcid":false,"given":"Corey M.","family":"Peak","sequence":"first","affiliation":[{"name":"Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Childs","sequence":"additional","affiliation":[{"name":"Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5646-1314","authenticated-orcid":false,"given":"Yonatan H.","family":"Grad","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115;"},{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline O.","family":"Buckee","sequence":"additional","affiliation":[{"name":"Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2004.1480"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02759"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06536"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.21.2711"},{"key":"e_1_3_3_5_2","unstructured":"; American Civil Liberties Union Yale Global Health Justice Partnership Fear Politics and Ebola. How Quarantines Hurt the Fight Against Ebola and Violate the Constitution . Available at https:\/\/www.aclu.org\/sites\/default\/files\/field_document\/aclu-ebolareport.pdf. Accessed March 10 2017. (2015)."},{"key":"e_1_3_3_6_2","unstructured":"; M\u00e9decins Sans Fronti\u00e8res (MSF) Ebola: Quarantine Can Undermine Efforts to Curb Epidemic . Available at www.msf.org\/article\/ebola-quarantine-can-undermine-efforts-curb-epidemic. Accessed March 10 2017. (2014)."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1413139"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj056"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1502918"},{"key":"e_1_3_3_10_2","volume-title":"Control of Communicable Diseases Manual","author":"Heymann DL","year":"2014","unstructured":", ed DL Heymann (APHA, 20th Ed, Washington, DC Control of Communicable Diseases Manual, 2014).","edition":"20"},{"key":"e_1_3_3_11_2","unstructured":"; World Health Organization International Health Regulations (World Health Organization Geneva Switzerland) 2nd Ed. (2005)."},{"key":"e_1_3_3_12_2","unstructured":"; Centers for Disease Control and Prevention Legal Authorities for Isolation and Quarantine . Available at https:\/\/www.cdc.gov\/quarantine\/pdf\/legal-authorities-isolation-quarantine.pdf. Accessed March 10 2017. (2014)."},{"key":"e_1_3_3_13_2","unstructured":"MA Rothstein Quarantine and Isolation: Lessons Learned from SARS . Available at www.iaclea.org\/members\/pdfs\/SARS%20REPORT.Rothstein.pdf. Accessed March 10 2017. (2003)."},{"key":"e_1_3_3_14_2","first-page":"500","article-title":"Controlling the last known cluster of Ebola virus disease\u2014Liberia, January\u2013February 2015","volume":"64","author":"Nyenswah T","year":"2015","unstructured":"T Nyenswah, , Controlling the last known cluster of Ebola virus disease\u2014Liberia, January\u2013February 2015. MMWR Morb Mortal Wkly Rep 64, 500\u2013504 (2015).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_3_15_2","unstructured":"; CDC Interim U.S. Guidance for Monitoring and Movement of Persons with Potential Ebola Virus Exposure . Available at https:\/\/www.cdc.gov\/vhf\/ebola\/exposure\/monitoring-and-movement-of-persons-with-exposure.html. Accessed October 3 2016. (2014)."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0968"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307506101"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04153"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05564"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411100"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu209"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.3620.944"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-480"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70069-6"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70304-9"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306742"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2014.02.001"},{"key":"e_1_3_3_28_2","volume-title":"Epidemiology and Prevention of Vaccine Preventable Diseases","author":"Centers for Disease Control and Prevention","year":"2015","unstructured":"; Centers for Disease Control and Prevention Epidemiology and Prevention of Vaccine Preventable Diseases, eds J Hamborsky, A Kroger, C Wolfe (Public Health Foundation, 13th Ed, Washington, DC, 2015).","edition":"13"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086616"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4682-5-20"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2011.01.001"},{"key":"#cr-split#-e_1_3_3_32_2.1","unstructured":"M Cetron S Maloney R Koppaka P Simone Isolation and quarantine: Containment strategies for SARS 2003. Institute of Medicine"},{"key":"#cr-split#-e_1_3_3_32_2.2","unstructured":"(US) Forum on Microbial Threats Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary eds Knobler S Mahmoud A Lemon S et al. (National Academies Press Washington DC). (2004)."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2014.12.002"},{"key":"e_1_3_3_34_2","unstructured":"; Centers for Disease Control and Prevention CDC Methods for Implementing and Managing Contact Tracing for Ebola Virus Disease in Less-Affected Countries . Available at https:\/\/stacks.cdc.gov\/view\/cdc\/26492. Accessed March 10 2017. (2014)."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-5564(99)00061-9"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir007"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000012"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2003.2481"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200104000-00004"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1109\/JPROC.2003.823142"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4757-3437-9_1","volume-title":"Sequential Monte Carlo Methods Practice","author":"Doucet A","year":"2001","unstructured":"A Doucet, N de Freitas, N Gordon, An introduction to sequential Monte Carlo methods. Sequential Monte Carlo Methods Practice (Springer, New York), pp. 3\u201314 (2001)."},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1109\/TSP.2010.2053707"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v008.i18"},{"key":"e_1_3_3_44_2","unstructured":"; WHO; CDC Implementation and Management of Contact Tracing for Ebola Virus Disease . Available at apps.who.int\/iris\/bitstream\/10665\/185258\/1\/WHO_EVD_Guidance_Contact_15.1_eng.pdf?ua=1. Accessed March 10 2017. (2015)."},{"key":"e_1_3_3_45_2","unstructured":"eds SW Roush LM Baldy Manual for the Surveillance of Vaccine-Preventable Diseases . Available at https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/index.html. Accessed March 10 2017. (2008)."},{"key":"e_1_3_3_46_2","unstructured":"; World Health Organization Global Health Sector Strategy on Viral Hepatitis . Available at apps.who.int\/iris\/bitstream\/10665\/246177\/1\/WHO-HIV-2016.06-eng.pdf?ua=1. Accessed March 10 2017. (2016)."},{"key":"e_1_3_3_47_2","unstructured":"; Centers for Disease Control and Prevention Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis . Available at https:\/\/www.cdc.gov\/flu\/avianflu\/novel-av-chemoprophylaxis-guidance.htm. Accessed March 10 2017. (2015)."},{"key":"e_1_3_3_48_2","unstructured":"; World Health Organization Pandemic Influenza Preparedness and Response . Available at apps.who.int\/iris\/bitstream\/10665\/44123\/1\/9789241547680_eng.pdf. Accessed March 10 2017. (2009)."},{"key":"e_1_3_3_49_2","unstructured":"; Centers for Disease Control and Prevention Interim U.S. Guidance for Monitoring and Movement of Persons with Potential Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Exposure . Available at https:\/\/www.cdc.gov\/coronavirus\/mers\/hcp\/monitoring-movement-guidance.pdf. Accessed March 10 2017. (2016)."},{"key":"e_1_3_3_50_2","unstructured":"; World Health Organization Rapid Advice Note on Home Care for Patients with Middle East Respiratory Syndrome Coronavirus (MERS-Cov) Infection Presenting with Mild Symptoms and Management of Contacts . Available at www.who.int\/csr\/disease\/coronavirus_infections\/MERS_home_care.pdf?ua=1. Accessed March 10 2017. (2013)."},{"key":"e_1_3_3_51_2","unstructured":"; World Health Organization Managing Pertussis Outbreaks During Humanitarian Emergencies . Available at apps.who.int\/iris\/bitstream\/10665\/69755\/1\/WHO_HSE_EPR_DCE_2008.2_eng.pdf. Accessed March 10 2017. (2008)."},{"key":"e_1_3_3_52_2","unstructured":"; Centers for Disease Control and Prevention Supplement D: Community Containment Measures Including Non-Hospital Isolation and Quarantine. Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2 . Available at https:\/\/www.cdc.gov\/sars\/guidance\/d-quarantine\/management.pdf. Accessed March 10 2017. (2004)."},{"key":"e_1_3_3_53_2","unstructured":"; World Health Organization WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS) . Available at www.who.int\/csr\/resources\/publications\/WHO_CDS_CSR_ARO_2004_1.pdf?ua=1. Accessed March 10 2017. (2004)."},{"key":"e_1_3_3_54_2","unstructured":"; Centers for Disease Control and Prevention Epidemiological Investigation . Available at https:\/\/www.cdc.gov\/smallpox\/bioterrorism-response-planning\/public-health\/epidemiological-investigation.html. Accessed March 10 2017. (2017)."},{"key":"e_1_3_3_55_2","unstructured":"; World Health Organization Frequently Asked Questions and Answers on Smallpox . Available at www.who.int\/csr\/disease\/smallpox\/faq\/en\/. Accessed March 10 2017. (2016)."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1616438114","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1616438114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T02:22:47Z","timestamp":1649816567000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1616438114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":56,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4,11]]}},"alternative-id":["10.1073\/pnas.1616438114"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1616438114","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/072652","asserted-by":"object"}]},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]},"assertion":[{"value":"2017-03-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}